PubMed HealthSearch

Biomedical subjects

E A Kennard

Publications and source records attributed to E A Kennard.

2 recordsLinked to original sources

Novel human endometrial cell line promotes blastocyst development.

OBJECTIVE: To test and contrast the embryotrophic potential of an established human endometrial cell line to that of two other epithelial cell types: human oviduct and African monkey kidney (Vero) cells. DESIGN: Mouse IVF was performed. Subsequent development of embryos cocultured with our endometrial cell line was contrasted to that seen with oviductal and Vero cell coculture systems. Percent blastocyst transformation, expansion, and hatching were compared. SETTING: University-based research laboratory associated with clinical IVF program. RESULTS: All three epithelial cell monolayers tested significantly improved the rate of blastocyst transformation of in vitro fertilized murine oocytes. The overall percent blastocysts obtained was highest with endometrial cells (69%), followed by oviductal cells (52%), Vero cells (45%), and the medium-alone controls (29%). Only 13% of oviduct cocultured embryos were able to reach the hatched blastocyst stage compared with a 30% hatching rate with endometrial cells and a 21% hatching rate with Vero cells. Only 3% of control embryos hatched in vitro. CONCLUSION: We have described a novel continuous endometrial cell line with excellent embryotrophic potential. This cell line is technically easy to use and is of human origin. As a coculture system it appears to be superior to both oviductal and Vero cells in correcting for defects in culture environment during in vitro development up to the blastocyst stage.

Aneuploidy

A program for matched, anonymous oocyte donation.

The authors' program for matched, anonymous oocyte donation has resulted in two successful pregnancies among the first eight oocyte recipients. All oocyte recipients to date have had ovarian failure or absence with premature ovarian failure the most common cause. All recipients were cycled on a program of incremental oral micronized estradiol and intramuscular progesterone-in-oil. Thirteen candidates for oocyte donation were screened to obtain 8 donors. One donor candidate was excluded because of her medical history. The psychological screening of 2 of the other donor candidates (who subsequently did not complete the donation cycle) revealed a primary motive of financial gain. In general, the psychological profiles of donor candidates revealed a high incidence of troubled families and either reproductive loss or loss of a parent. Ovarian stimulation of the donors followed our standard in vitro fertilization protocol. The recipients' exogenous steroid replacement continued until days 97 and 101, respectively, of the two gestations. Both pregnancies resulted in the delivery of normal singleton males--the first at 40 weeks, the second at 35 weeks.

Adult